Acute neurosteroids inhibit the spinal reflex potentiation via GABAergic neurotransmission

Junn Liang Chang, Hsien Yu Peng, Hsi Chin Wu, Hsiao Ting Lu, Shwu Fen Pan, Mei Jung Chen, Tzer Bin Lin

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Recently, we demonstrated a chronic neurosteroid-dependent inhibition of activity-dependent spinal reflex potentiation (SRP), but it remains unclear whether neurosteroids acutely modulate SRP induction. This study shows progesterone as well as two of its 3α,5α-derivatives, allopregnalonone and 3α,5α-tetrahydrodeoxycorticosterone (THDOC), to be capable of producing acute GABAA receptor (GABA AR)-dependent inhibition of SRP. When compared with test simulation (1 stimulation/30 s) of pelvic afferent nerves that evoked a baseline reflex activity in an external urethra sphincter electromyogram, repetitive stimulation (RS; 1 stimulation/1 s) induced SRP characterized by an increase in the evoked activity. Intrathecal progesterone (3-30 μM, 10 μl) at 10 min before stimulation onset dose dependently prevented RS induction. Intrathecal allopregnalonone (10 μM, 10 μl it) and THDOC (10 μM, 10 μl it) also prevented the SRP caused by RS. Pretreatment with the GABAAR antagonist bicuculline (10 μM, 10 μl it) at 1 min before progesterone/neurosteroid injection attenuated the inhibition of SRP caused by progesterone, allopregnanolone, and THDOC. Results suggest that progesterone and its neurosteroid metabolites may be crucial to the development of pelvic visceral neuropathic/postinflammatory pain and imply clinical use of neurosteroids, such as allopregnanolone and THDOC, for visceral pain treatment.

Original languageEnglish
JournalAmerican Journal of Physiology - Renal Physiology
Volume299
Issue number1
DOIs
Publication statusPublished - Jul 2010
Externally publishedYes

Fingerprint

Synaptic Transmission
Neurotransmitter Agents
Reflex
Progesterone
Pregnanolone
Visceral Pain
Bicuculline
Neuralgia
Electromyography
Urethra
GABA-A Receptors
Injections
tetrahydrodeoxycorticosterone
Inhibition (Psychology)

Keywords

  • Hypergesia
  • Progesterone
  • Spinal cord
  • Urethra
  • Visceral pain

ASJC Scopus subject areas

  • Physiology
  • Urology

Cite this

Acute neurosteroids inhibit the spinal reflex potentiation via GABAergic neurotransmission. / Chang, Junn Liang; Peng, Hsien Yu; Wu, Hsi Chin; Lu, Hsiao Ting; Pan, Shwu Fen; Chen, Mei Jung; Lin, Tzer Bin.

In: American Journal of Physiology - Renal Physiology, Vol. 299, No. 1, 07.2010.

Research output: Contribution to journalArticle

Chang, Junn Liang ; Peng, Hsien Yu ; Wu, Hsi Chin ; Lu, Hsiao Ting ; Pan, Shwu Fen ; Chen, Mei Jung ; Lin, Tzer Bin. / Acute neurosteroids inhibit the spinal reflex potentiation via GABAergic neurotransmission. In: American Journal of Physiology - Renal Physiology. 2010 ; Vol. 299, No. 1.
@article{963a33977edb4cf5ba16df5bb0b27307,
title = "Acute neurosteroids inhibit the spinal reflex potentiation via GABAergic neurotransmission",
abstract = "Recently, we demonstrated a chronic neurosteroid-dependent inhibition of activity-dependent spinal reflex potentiation (SRP), but it remains unclear whether neurosteroids acutely modulate SRP induction. This study shows progesterone as well as two of its 3α,5α-derivatives, allopregnalonone and 3α,5α-tetrahydrodeoxycorticosterone (THDOC), to be capable of producing acute GABAA receptor (GABA AR)-dependent inhibition of SRP. When compared with test simulation (1 stimulation/30 s) of pelvic afferent nerves that evoked a baseline reflex activity in an external urethra sphincter electromyogram, repetitive stimulation (RS; 1 stimulation/1 s) induced SRP characterized by an increase in the evoked activity. Intrathecal progesterone (3-30 μM, 10 μl) at 10 min before stimulation onset dose dependently prevented RS induction. Intrathecal allopregnalonone (10 μM, 10 μl it) and THDOC (10 μM, 10 μl it) also prevented the SRP caused by RS. Pretreatment with the GABAAR antagonist bicuculline (10 μM, 10 μl it) at 1 min before progesterone/neurosteroid injection attenuated the inhibition of SRP caused by progesterone, allopregnanolone, and THDOC. Results suggest that progesterone and its neurosteroid metabolites may be crucial to the development of pelvic visceral neuropathic/postinflammatory pain and imply clinical use of neurosteroids, such as allopregnanolone and THDOC, for visceral pain treatment.",
keywords = "Hypergesia, Progesterone, Spinal cord, Urethra, Visceral pain",
author = "Chang, {Junn Liang} and Peng, {Hsien Yu} and Wu, {Hsi Chin} and Lu, {Hsiao Ting} and Pan, {Shwu Fen} and Chen, {Mei Jung} and Lin, {Tzer Bin}",
year = "2010",
month = "7",
doi = "10.1152/ajprenal.00632.2009",
language = "English",
volume = "299",
journal = "American Journal of Physiology - Renal Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "1",

}

TY - JOUR

T1 - Acute neurosteroids inhibit the spinal reflex potentiation via GABAergic neurotransmission

AU - Chang, Junn Liang

AU - Peng, Hsien Yu

AU - Wu, Hsi Chin

AU - Lu, Hsiao Ting

AU - Pan, Shwu Fen

AU - Chen, Mei Jung

AU - Lin, Tzer Bin

PY - 2010/7

Y1 - 2010/7

N2 - Recently, we demonstrated a chronic neurosteroid-dependent inhibition of activity-dependent spinal reflex potentiation (SRP), but it remains unclear whether neurosteroids acutely modulate SRP induction. This study shows progesterone as well as two of its 3α,5α-derivatives, allopregnalonone and 3α,5α-tetrahydrodeoxycorticosterone (THDOC), to be capable of producing acute GABAA receptor (GABA AR)-dependent inhibition of SRP. When compared with test simulation (1 stimulation/30 s) of pelvic afferent nerves that evoked a baseline reflex activity in an external urethra sphincter electromyogram, repetitive stimulation (RS; 1 stimulation/1 s) induced SRP characterized by an increase in the evoked activity. Intrathecal progesterone (3-30 μM, 10 μl) at 10 min before stimulation onset dose dependently prevented RS induction. Intrathecal allopregnalonone (10 μM, 10 μl it) and THDOC (10 μM, 10 μl it) also prevented the SRP caused by RS. Pretreatment with the GABAAR antagonist bicuculline (10 μM, 10 μl it) at 1 min before progesterone/neurosteroid injection attenuated the inhibition of SRP caused by progesterone, allopregnanolone, and THDOC. Results suggest that progesterone and its neurosteroid metabolites may be crucial to the development of pelvic visceral neuropathic/postinflammatory pain and imply clinical use of neurosteroids, such as allopregnanolone and THDOC, for visceral pain treatment.

AB - Recently, we demonstrated a chronic neurosteroid-dependent inhibition of activity-dependent spinal reflex potentiation (SRP), but it remains unclear whether neurosteroids acutely modulate SRP induction. This study shows progesterone as well as two of its 3α,5α-derivatives, allopregnalonone and 3α,5α-tetrahydrodeoxycorticosterone (THDOC), to be capable of producing acute GABAA receptor (GABA AR)-dependent inhibition of SRP. When compared with test simulation (1 stimulation/30 s) of pelvic afferent nerves that evoked a baseline reflex activity in an external urethra sphincter electromyogram, repetitive stimulation (RS; 1 stimulation/1 s) induced SRP characterized by an increase in the evoked activity. Intrathecal progesterone (3-30 μM, 10 μl) at 10 min before stimulation onset dose dependently prevented RS induction. Intrathecal allopregnalonone (10 μM, 10 μl it) and THDOC (10 μM, 10 μl it) also prevented the SRP caused by RS. Pretreatment with the GABAAR antagonist bicuculline (10 μM, 10 μl it) at 1 min before progesterone/neurosteroid injection attenuated the inhibition of SRP caused by progesterone, allopregnanolone, and THDOC. Results suggest that progesterone and its neurosteroid metabolites may be crucial to the development of pelvic visceral neuropathic/postinflammatory pain and imply clinical use of neurosteroids, such as allopregnanolone and THDOC, for visceral pain treatment.

KW - Hypergesia

KW - Progesterone

KW - Spinal cord

KW - Urethra

KW - Visceral pain

UR - http://www.scopus.com/inward/record.url?scp=77953821187&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953821187&partnerID=8YFLogxK

U2 - 10.1152/ajprenal.00632.2009

DO - 10.1152/ajprenal.00632.2009

M3 - Article

VL - 299

JO - American Journal of Physiology - Renal Physiology

JF - American Journal of Physiology - Renal Physiology

SN - 1931-857X

IS - 1

ER -